Health Network Communications recently interviewed Stefanie Thomas, Drug Assessment, IQWiG on what she thought the top issues impacting pharmaceutical market access were, and how she addressed these issues. Ms Thomas believes the top 3 issues impacting pharmaceutical market access are:"Maintenance of affordable high-quality health care; area of conflict between early ...

Dr. Falk Pharma GmbH and Lipid Therapeutics, a biotechnology company focused on novel treatments for inflammatory bowel disease, today announced that they have entered into a licensing agreement for the European rights to Lipid Therapeutics' lead product, LT-02, for ulcerative colitis.

Tightening regulations, increasing healthcare costs, ever-growing budget restrictions - these are just a few of the concerns that are raising the attention of key pharma stakeholders throughout the region of CEE, CIS, SEE countries and Turkey. In this new market reality, pharma companies still need to find a way to ...

The current situation in the pharma industry is characterized by the increased counterfeiting and non-compliance practices which represent major obstacles to providing the best healthcare for patients. At the same time, pharma packagers have to deal with the newest waves of regulations, process optimization hurdles as well as patient ...

Mylan Inc. today announced that it plans to change the name of its fully integrated branded specialty pharmaceutical business from Dey Pharma to Mylan Specialty.

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

Swiss pharmaceutical firm Novartis said Sunday it was recalling four different products sold over the counter in the United States over reports of a malfunction at one of its plants.

Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories - public and private financings, fast growing companies, acquisitions and SBIR grants - reflecting a broad range of activity.

Wolters Kluwer, a market-leading global information services company focused on professionals, today announced that it has completed the sale of its pharma-related Marketing & Publishing Services business to Springer Science+Business Media.

The eye is the most easily accessible site for topical administration of a medication. Drugs are commonly applied to the eye for localised action on the surface or in the interior of the eye. A major problem in ocular therapeutics is the attainment of an optimal drug concentration at the ...

Anti-counterfeiting, packaging safely via redesign, 2D barcoding integrity and artwork management updates are among the major themes of Fleming Europe's 2nd Annual Pharma Packaging & Labeling Compliance Conference which is once again bringing you three days of ground-breaking debate and pioneering case studies from top industry, regulatory and association experts: ...

The European Commission has granted a marketing authorization for DIFICLIR™ (fidaxomicin) tablets to treat adults with Clostridium difficile infections (CDI), also known as C. difficile-associated diarrhea (CDAD), in the European Union. The announcement was made by Astellas Pharma Europe Ltd., a European subsidiary of Tokyo-based Astellas Pharma Inc. and Optimer ...